PB2312: REACTIVATION OF HEPATITIS B VIRUS FOLLOWING RITUXIMAB IN B LYMPHOID HEMOPATHIES

PB2312: REACTIVATION OF HEPATITIS B VIRUS FOLLOWING RITUXIMAB IN B LYMPHOID HEMOPATHIES

Bibliographic Details
Main Authors:	Miled Wafa, Dorra Jabeur, Raoudha Mansouri, Malek Sayedi, Karima Kacem, Raihane Ben Lakhal
Format:	Article
Language:	English
Published:	Wiley 2023-08-01
Series:	HemaSphere
Online Access:	http://journals.lww.com/10.1097/01.HS9.0000975972.95792.dd

Similar Items

PB2368: THE PRE-EMPTIVE STRATEGY OF HEPATITIS B VIRAL REACTIVATION IN PATIENTS WITH MALIGNANT HEMOPATHIES RECEIVING IMMUNSUPPRESSIVE THERAPY IN TUNISIA
by: Miled Wafa, et al.
Published: (2023-08-01)

PB1875: TREATMENT OF YOUNGER PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA IN TUNISIA: FCR STILL STANDARD FOR FIRST-LINE THERAPY
by: W. Miled, et al.
Published: (2022-06-01)

PB2120: HIV AND MALIGNANT HEMOPATHIES
by: H. Khibri, et al.
Published: (2022-06-01)

PB2320: FIRST LINE THERAPY FOR DIFFUSE LARGE B CELL LYMPHOMA AMONG THE ELDERLY: A TUNISIAN MULTICENTER EXPERIENCE.
by: Kmira Zahra, et al.
Published: (2023-08-01)

Vexas: A new syndrome not always associated with hemopathy
by: Benoît Thomas, et al.
Published: (2022-02-01)

PB2340: FIRST LINE THERAPY FOR DIFFUSE LARGE B CELL LYMPHOMA AMONGPATIENTS AGED LESS THAN 60 YEARS: A TUNISIAN MULTICENTER EXPERIENCE.
by: Kmira Zahra, et al.
Published: (2023-08-01)

PB2071: INTRALESIONAL RITUXIMAB IN THE TREATMENT OF PRIMARY CUTANEOUS B-CELL LYMPHOMA
by: M. Callejas Charavia, et al.
Published: (2022-06-01)

Exophthalmos revealing of a malignant hemopathy in children about three cases
by: Kheira KERROUCHE, et al.
Published: (2021-12-01)

CYTOLOGIE DES HEMOPATHIES MALIGNES DE TYPE MYELOIDE A KINSHASA
by: NZ. Kayembe, et al.
Published: (2014-12-01)

Primary Adrenal Lymphoma
by: Karima Kacem, et al.
Published: (2014-05-01)

Modèle de soins partagés pour les hémopathies malignes chroniques complexes
by: Verna Cheung, et al.
Published: (2021-05-01)

Hidden in the Eyes—Recurrence of Systemic Hemopathies Reportedly “In Remission”: Six Cases and Review of Literature
by: Margot Denier, et al.
Published: (2022-03-01)

PB1719: NIRAPARIB IN B-CELL LYMPHOID MALIGNANCIES: EXPLORING SYNTHETIC LETHALITY AS TARGET FOR THERAPY
by: Beatriz Lapa, et al.
Published: (2023-08-01)

Hereditary predisposition to malignant myeloid hemopathies: Caution in use of saliva and guideline based on our experience
by: Alexandre Perani, et al.
Published: (2023-02-01)

Communication between bone marrow niches in normal bone marrow function and during hemopathies progression
by: Sara Lamorte, et al.
Published: (2009-08-01)

PB1731: INOTUZUMAB OZOGAMICIN IN LYMPHOID B-CELL MALIGNANCY：A SINGLE CENTER ANALYSIS IN THE REAL WORLD
by: Mengnan LV, et al.
Published: (2023-08-01)

PB1878: MYELOID SARCOMA IN CHILDREN: ABOUT 9 CASES
by: Ameni Yahia, et al.
Published: (2023-08-01)

Rituximab capping triggers intracellular reorganisation of B cells
by: Koller, T, et al.
Published: (2017)

Gingival Leukemic Infiltration in Chronic Lymphocytic Leukemia
by: Karima Kacem, et al.
Published: (2019-11-01)

PB2097: ZANUBRUTINIB PLUS RITUXIMAB FOR THE TREATMENT OF ELDERLY UNFIT PATIENTS WITH PREVIOUSLY UNTREATED DIFFUSE LARGE-B CELL LYMPHOMA
by: J.-F. Bai, et al.
Published: (2022-06-01)

Metabolic gatekeeper function of B-lymphoid transcription factors
by: Chan, LN, et al.
Published: (2017)

The Impact of Hyperosmolality on Activation and Differentiation of B Lymphoid Cells
by: Ljiljana Cvetkovic, et al.
Published: (2019-04-01)

Is Rituximab-Associated Hypogammaglobulinemia Always Linked to B-Cell Depletion?
by: Anthie Damianaki, et al.
Published: (2022-02-01)

Deciphering Biomarkers for Leptomeningeal Metastasis in Malignant Hemopathies (Lymphoma/Leukemia) Patients by Comprehensive Multipronged Proteomics Characterization of Cerebrospinal Fluid
by: Pablo Juanes-Velasco, et al.
Published: (2022-01-01)

A case report of hepatitis B virus reactivation 19 months after cessation of chemotherapy with rituximab
by: Xiangjuan Guo, et al.
Published: (2022-12-01)

PB2558: REFERENCE VALUES FOR METHEMOGLOBIN LEVEL AND NADH-CYTOCHROME B5 REDUCTASE ACTIVITY IN TUNISIAN POPULATION.
by: Emna Bouatrous, et al.
Published: (2023-08-01)

EVALUATION OF CYTOKINE GENE POLYMORPHISM IN B CELL LYMPHOID MALIGNANCIES
by: E. L. Nazarova, et al.
Published: (2014-11-01)

In vitro effects of rituximab on the proliferation, activation and differentiation of human B cells.
by: Kamburova, E, et al.
Published: (2012)

Intralesional and systemic rituximab in the treatment of primary cutaneous B‐cell lymphoma
by: Jake G. Besch‐Stokes, et al.
Published: (2023-12-01)

Treatment of Indolent Cutaneous B-Cell Lymphoma with Intralesional or Intravenous Rituximab
by: Christian Menzer, et al.
Published: (2022-09-01)

Administration of monoclonal antibodies to b-lymphocytes (rituximab) in rheumatoid arthritis in Russia
by: E L Nasonov, et al.
Published: (2008-08-01)

B-cell depletion and primary Sjögren’s syndrome: is there a role for rituximab?
by: P. Sarzi-Puttini, et al.
Published: (2011-06-01)

PB2344: RESILIENCE IN PATIENTS WITH LYMPHOID MALIGNANCIES: THE REPLY STUDY.
by: G. Dos Santos, et al.
Published: (2022-06-01)

PB2286: EVALUATION OF THE THERAPEUTIC RESULTS OF LYMPHOBLASTIC LYMPHOMA TREATED ACCORDING TO THE EORTC 58951 PROTOCOL IN CHILDREN ADOLESCENTS AND YOUNG ADULTS
by: Hana Ben Hammamia, et al.
Published: (2023-08-01)

PB2365: CHILDHOOD BURKITT LYMPHOMA: ABOUT 31 CASES (EXPERIENCE OF THE PEDIATRIC CLINICAL HEMATOLOGY DEPARTMENT OF AZIZA OTHMANA’S HOSPITAL)
by: Nefzi Rihab, et al.
Published: (2023-08-01)

P1224: EFFICACY OF RITUXIMAB AND BIOSIMILAR RITUXIMAB IN UNTREATED DIFFUSE LARGE B-CELL LYMPHOMA, A DANISH POPULATION BASED ANALYSIS
by: A. Haujir, et al.
Published: (2022-06-01)

03.03 Tertiary lymphoid structures in pancreatic cancer resemble lymphoid follicles in secondary lymphoid organs as sites for initiation and maintenance of anti-tumor T- and B-cell responses
by: J Werner, et al.
Published: (2024-03-01)

The Effect of the Tumor Microenvironment on Lymphoid Neoplasms Derived from B Cells
by: Giuseppe Ingravallo, et al.
Published: (2022-02-01)

B-Lymphoid Blast Phase–Chronic Myeloid Leukemia: Current Therapeutics
by: Binoy Yohannan, et al.
Published: (2022-10-01)

Editorial: Role of the antigen receptor in the pathogenesis of B-cell lymphoid malignancies
by: Andreas Agathangelidis, et al.
Published: (2023-03-01)